Research Alliance Corporation III Class A Ordinary Shares
RACC
NASDAQ Global Market10.72
USD
-0.03
- -
Research Alliance Corporation III Class A Ordinary Shares
RACC
(NASDAQ Global Market)
Recent
price
10.72
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Research Alliance Corporation III Class A Ordinary Shares (RACC) operates as a blank-check company sponsored by an affiliate of RA Capital Management, L.P., formed to effect a merger, share exchange, asset acquisition, or other business combination with one or more target businesses. The company plans to list on the Nasdaq Capital Market and trade under the ticker RACC on launch, with a focused mandate to identify and consummate a qualifying merger or acquisition within a defined timeline. Main products and services - Corporate vehicle for mergers and acquisitions: Establishes a publicly traded vehicle to pursue one or more business combinations with a target company. - Capital raise and trust structure: Provides an initial public offering of Class A ordinary shares to raise funds; maintains a trust account for capital deployment and transaction financing. - Acquisition search and execution platform: Engages in identifying, evaluating, and negotiating potential merger targets; coordinates due diligence, valuation, and deal structuring; arranges financing and regulatory approvals for a business combination. - Post-merger integration and value creation support: Facilitates transition services, strategic alignment, and governance setup for the combined entity post-transaction. Latest major company changes - Initial public offering pricing and listing: Announces pricing of an initial public offering of Class A ordinary shares at $10 per share and plans to list on the Nasdaq Capital Market under the ticker RACC; anticipated closing subject to customary conditions (May 2026). This marks the company’s transition from blank-check sponsor to a publicly traded merger vehicle ready to pursue a target (PR Newswire, May 20, 2026). - Sponsorship and leadership alignment: The SPAC is sponsored by an affiliate of RA Capital Management, L.P., with CEO and COO/CBO leadership established to oversee the IPO process and target evaluation (PR Newswire, May 20, 2026). - Public market introduction and investor liquidity provisions: Nasdaq Capital Market listing and initial liquidity provision via 7,500,000 Class A shares in the IPO, establishing a platform for future acquisitions and equity markets participation (FT Markets, May 19–20, 2026). Additional context - Industry and segments: Special purpose acquisition company (SPAC) focused on identifying and acquiring or merging with a private company to create a publicly traded entity; operates within the financial services and corporate finance ecosystem. - Target markets and customers: Primarily institutional and high-net-worth investors seeking exposure to a de-SPAC target; corporate targets across industries seeking a public listing via SPAC merger. - Geographic footprint: United States-listed vehicle; operations and target searches conducted globally, with regulatory and financial markets coordination in the U.S.; headquarters not publicly disclosed in the available materials. - Founding year and headquarters: Formed in 2026 as a SPAC; is positioned as a California/USA-listed entity with strategic sponsor ties to RA Capital Management; precise corporate headquarters location not specified in the latest disclosures. - Subsidiaries and parent relationships: Parent/ sponsor relationship with an affiliate of RA Capital Management, L.P.; no other significant subsidiaries disclosed in the recent filings. Notes - RACC’s primary objective is to consummate a strategic transaction with one or more target businesses; until a deal is completed, the entity holds cash raised from the IPO in a trust, and its operating activities are limited to identifying and negotiating potential acquisitions. - The latest public disclosures emphasize the IPO pricing, listing, and sponsor background, with formal target identification and merger execution activities expected post-close of the offering.
Company News
Oak Hill Bio and Research Alliance Corporation III Announce Business Combination Agreement to Create Publicly Listed Rare Disease Biotechnology Company to Advance Antisense Oligonucleotide Therapy Rugonersen for Angelman Syndrome